Literature DB >> 7578417

Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells.

S Teramoto1, L G Johnson, W Huang, M W Leigh, R C Boucher.   

Abstract

Although recombinant adenoviruses are used as vectors for delivering therapeutic genes to the airways of cystic fibrosis (CF) patients, the effects of these vectors on the kinetics of airway epithelial cell growth have not been investigated. We tested whether E1, E3-deleted Ad vectors (Ad5-CMV-lacZ) affect the kinetics of cell proliferation of human airway epithelial cells in primary culture. There was a dose-dependent relationship between the vector multiplicity of infection (moi) and the efficiency of Ad-mediated lacZ gene transfer. Growth curves of cells exposed to vector were shifted to the right as compared to vehicle in a dose-dependent manner. The vector-induced slowing of cell proliferation resulted from both (i) increased apoptotic cell death and (ii) lower recruitment into S phase. UV inactivation of the vector genes abolished the effects on cell proliferation. These data demonstrate that as the moi of vectors is increased to achieve effective gene transfer, apoptosis and slowing of the cell cycle of infected cells increases concomitantly. The identification and inactivation of these vector effects on human airway cells may be important for reducing the toxicity of adenovirus vectors for gene therapy of CF airways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578417     DOI: 10.1089/hum.1995.6.8-1045

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  12 in total

1.  An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency.

Authors:  B T Tan; L Wu; A J Berk
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 2.  Roles of apoptosis in airway epithelia.

Authors:  Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-26       Impact factor: 6.914

3.  Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins.

Authors:  R P Wersto; E R Rosenthal; P K Seth; N T Eissa; R E Donahue
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

4.  Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines.

Authors:  A Segerman; Y F Mei; G Wadell
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Helper-dependent adenoviral vectors are superior in vitro to first-generation vectors for endothelial cell-targeted gene therapy.

Authors:  Rowan Flynn; Joshua M Buckler; Chongren Tang; Francis Kim; David A Dichek
Journal:  Mol Ther       Date:  2010-08-31       Impact factor: 11.454

6.  Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction.

Authors:  C P Hsu; J M Hilfinger; E Walter; H P Merkle; B J Roessler; G L Amidon
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

Review 7.  Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis.

Authors:  Duncan E Keegan; John J Brewington
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

8.  Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin.

Authors:  Assaf Shapira; Shiran Shapira; Meital Gal-Tanamy; Romy Zemel; Ran Tur-Kaspa; Itai Benhar
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  Activation of P2X(7) receptor by ATP plays an important role in regulating inflammatory responses during acute viral infection.

Authors:  Benjamin H Lee; David M Hwang; Nades Palaniyar; Sergio Grinstein; Dana J Philpott; Jim Hu
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

10.  p16 Gene transfer increases cell killing with abnormal nucleation after ionising radiation in glioma cells.

Authors:  S Hama; S Matsuura; H Tauchi; F Yamasaki; Y Kajiwara; K Arita; H Yoshioka; Y Heike; K Mandai; K Kurisu
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.